FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039389 [Registered on: 13/01/2022] Trial Registered Prospectively
Last Modified On: 11/01/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical analysis of incidence of Urinary tract infection and stent related symptoms in patients following surgery for renal stones. 
Scientific Title of Study   A clinical randomised analysis of incidence of Urinary tract infection and stent related symptoms in patients with peri interventional antibiotic prophylaxis only versus low dose continuous antibiotic treatment in patients with DJ stent. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pramod Makannavar 
Designation  Assistant Professor 
Affiliation  SDM Medical college and hospital, 
Address  Department of Urology SDM Kedical college and hospital Sattur Dharwad
Department of Urology SDM Medical college and hospital Sattur Dharwad, 580009
Dharwad
KARNATAKA
580009
India 
Phone  8971883525  
Fax  918662461651  
Email  drpramod.0702@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Pramod Makannavar 
Designation  Assistant Professor 
Affiliation  SDM Medical college and hospital, 
Address  Department of Urology SDM Medical college and hospital Sattur Dharwad, 580009
Department of Urology SDM Medical college and hospital Sattur Dharwad, 580009
Dharwad
KARNATAKA
580009
India 
Phone  8971883525  
Fax  918662461651  
Email  drpramod.0702@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pramod Makannavar 
Designation  Assistant Professor 
Affiliation  SDM Medical college and hospital, 
Address  Department of Urology SDM Medical college and hospital Sattur Dharwad, 580009
Department of Urology SDM Medical college and hospital Sattur Dharwad, 580009
Dharwad
KARNATAKA
580009
India 
Phone  8971883525  
Fax  918662461651  
Email  drpramod.0702@gmail.com  
 
Source of Monetary or Material Support  
SDM Medical college and hospital Sattur Dharwad, Karnataka 
 
Primary Sponsor  
Name  Pramod Makannavar 
Address  Department of Urology SDM Medical college and hospital Sattur Dharwad, 580009 Karnataka  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
pramod makannavar  Department of Urology, SDM Medical college  Sattur Dharwad, 580009
Dharwad
KARNATAKA 
8971883525
918662461651
drpramod.0702@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SDM institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N202||Calculus of kidney with calculus of ureter,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  low dose continuous antibiotic treatment for entire stent indwelling time.  Patients who have undergone endourological procedures for uncomplicated upper urinary tract urolithiasis and who are on double j stent (DJ stent) and those who fulfill inclusion criteria will be included in comparator group. These patients along with peri interventional antibiotic prophylaxis will also receive low dose continuous antibiotic treatment for entire stent indwelling time, that is nitrofurantoine tablet 100 mg at bedtime from the time of discharge up to removal of stent (4 weeks). 
Intervention  Peri interventional antibiotic prophylaxis only  Patients who have undergone endourological procedures for uncomplicated upper urinary tract urolithiasis and who are on double j stent (DJ stent) and those who fulfill inclusion criteria will be included in intervention group. These patients will be given only perioperative antibiotics, that is intravenous cefotaxime 1 gm at the time of anaesthesia induction and twice per day on post operative for 1 day. No continuous antibiotic prophylaxis for entire stent indwelling time. 
 
Inclusion Criteria  
Age From  14.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  sterile urine culture prior to procedure,
complete stone clearance,
no fever or antibiotic treatment within past 2 weeks of procedure. 
 
ExclusionCriteria 
Details  Positive urine culture prior to surgery,
incomplete stone clearance,
patients who are already on antibiotics. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
incidence of Urinary tract infection and stent related symptoms in patients with peri interventional antibiotic prophylaxis only versus low dose continuous antibiotic treatment in patients with (double j)DJ stent.  incidence of Urinary tract infection and stent related symptoms in patients with peri interventional antibiotic prophylaxis only versus low dose continuous antibiotic treatment in patients with (double j)DJ stent. Patients will be assessed at 1,2 and 4 weeks following surgery with symptoms pertaning to stent insitu and urine culture. 
 
Secondary Outcome  
Outcome  TimePoints 
Patients will also be assessed for drug related side effects like gastrointestinal side effects and respiratory symptoms in those who have been given continuous antibiotic treatment for entire stent indwelling time.  patients will be assessed at 1,2 and 4 weeks of follow up. 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/03/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [drpramod.0702@gmail.com].

  6. For how long will this data be available start date provided 08-04-2023 and end date provided 08-04-2025?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  

Introduction: Placement of double J stent (DJ stent) is routine following endourological surgical interventions for urinary tract stone disease. Main complications following these procedures are urinary tract infection (UTI) and stent related symptoms (SRS ), which hamper daily activities. There is lack of literature about appropriate antibiotic strategy following uncomplicated endourological surgery for upper urinary tract stone disease in patients who are on DJ stent. Many clinicians give a continuous low dose antibiotic treatment for entire stent indwelling time to prevent UTI and also possibly reduce SRS. Our study will be conducted to evaluate incidence of UTI and stent related symptoms (SRS) in patients given a peri interventional antibiotic prophylaxis only vs a continuous low dose antibiotic treatment for entire stent indwelling time.

Objectives: To evaluate incidence of UTI and SRS in patients given a peri interventional antibiotic prophylaxis only vs a continuous low dose antibiotic treatment for entire stent indwelling time.Also to note any drug related side effects.

Methods: All patients will be evaluated with thorough medical history, physical examination, blood chemistry test, midstream urine sample analysis and culture. All patients will receive peri interventional antibiotic prophylaxis that is intravenous cefotaxime 1 gm at the time of anaesthesia induction. Patients who had complete stone clearance with DJ stent placed will be selected for the study. Patients will be randomised into 2 groups by lottery method or odd or even number. Group A – No antibiotic treatment from the time of discharge up to removal of the stent (4 weeks). Group B – Low dose continuous antibiotic treatment for entire stent indwelling time, that is nitrofurantoine tablet 100 mg at bedtime from the time of discharge up to removal of stent (4 weeks).

Inclusion criteria - sterile urine culture prior to procedure, complete stone clearance, no fever or antibiotic treatment within past 2 weeks of procedure.

Exclusion criteria – Positive urine culture prior to surgery, incomplete stone clearance, patients who are already on antibiotics.

Total sample of 100 cases will be considered through convenience type of sampling (on an average 8-10 patients are operated for upper urinary tract urolithiasis in an month, overall 120 cases in an year. Considering 10% may not be willing to give consent and10% may not fit into inclusion criteria).

Of these 100 patients, 2 groups will be made with 50 patients in each group.

Follow-up evaluation

   Patients will be evaluated at 1, 2 and 4 weeks for Stent related symptoms and urine culture evaluation. Clinical symptoms of UTI and SRS are very similar, therefore positive urine culture will be used to distinguish UTI from SRS. Clinical symptoms with positive urine culture will be considered as UTI, and clinical symptoms with negative urine culture will be considered symptoms related to stent insitu. Our primary objective will be UTI and secondary objective will be SRS and drug side effects. Any patients with symptomatic UTI will be given full dose antibiotic treatment according to antibiotic resistance pattern. Drug side effects will also be evaluated like gastro intestinal symptoms, cough.

 

.


 
Close